When researchers gave four patients with autoimmune diseases a bispecific antibody targeting BCMA on B cells and CD3 on T cells, there was a “significant signal toward hypogammaglobulinemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback